MedTrace Logo

Hybrid Method Between Low-ratio Premixed Insulin and Short Acting Insulin in Fasting Type 2 Diabetic Patients in Ramadan

NCT06528002 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2025-01-31

No results posted yet for this study

Summary

All healthy Muslim adults are required to observe the Ramadan fast, which is one of Islam's five pillars. People with Type 2 Diabetes Mellitus(T2DM). frequently fast throughout Ramadan. However, many Muslim patients insist on fasting in spite of medical warning. So, the investigators aim in the current study to assess safety and efficacy of our hybrid method using of low-ratio premixed insulin take at Iftar and short acting insulin take at Suhoor compare to last recommendation of IDF guideline of using low-ratio premix insulin regimens in type 2 diabetic patients who insist on Ramadan fasting.

Conditions

  • Continous Blood Glucose Monitoring
  • Calculation of Body Mass Index
  • Measurment of Blood Pressure

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Sara Kasem Abdelal, lecturer · sohag university .faculty of medicine

  • Ahmed Faysal El_Rawy, lecturer · sohag university .faculty of medicine

  • Marwa zanaty Elsayed, lecturer · sohag university .faculty of medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-05-15
Completion
2024-06-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06528002 on ClinicalTrials.gov